|
Volumn 43, Issue 9, 2011, Pages 3541-3544
|
Biologics and donor bone marrow cells for targeted immunomodulation in vascularized composite allotransplantation: A translational trial in swine
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BASILIXIMAB;
CYTOTOXIC T LYMPHOCYTE ANTIGEN 4 ANTIBODY;
METHYLPREDNISOLONE SODIUM SUCCINATE;
TACROLIMUS;
ACUTE GRAFT REJECTION;
ALLOGRAFT;
ALLOTRANSPLANTATION;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
BONE;
BONE MARROW CELL;
CLINICAL PROTOCOL;
CONFERENCE PAPER;
CONTROLLED STUDY;
FEMALE;
GRAFT REJECTION;
GRAFT SURVIVAL;
HISTOPATHOLOGY;
IMMUNOLOGICAL TOLERANCE;
IMMUNOMODULATION;
IMMUNOSUPPRESSIVE TREATMENT;
MALE;
MICROCHIMERISM;
MUSCLE;
NONHUMAN;
POSTOPERATIVE PERIOD;
PRIORITY JOURNAL;
RADIAL NERVE;
SKIN;
SURVIVAL;
SWINE;
THYMUS;
VASCULARIZED COMPOSITE ALLOTRANSPLANTATION;
WHOLE BODY RADIATION;
ANIMALS;
ANTIGENS;
BIOLOGICAL PRODUCTS;
BONE MARROW CELLS;
BONE MARROW TRANSPLANTATION;
CHIMERISM;
CTLA-4 ANTIGEN;
EXTREMITIES;
FEMALE;
GRAFT SURVIVAL;
IMMUNOSUPPRESSION;
MALE;
MODELS, ANIMAL;
SWINE;
SWINE, MINIATURE;
TACROLIMUS;
TRANSLATIONAL MEDICAL RESEARCH;
TRANSPLANTATION, HOMOLOGOUS;
|
EID: 81455132393
PISSN: 00411345
EISSN: 18732623
Source Type: Journal
DOI: 10.1016/j.transproceed.2011.10.010 Document Type: Conference Paper |
Times cited : (22)
|
References (8)
|